glp-1 retatrutide PDB-101: Molecule of the Month: Receptor Agonists Retatrutide for weight loss: Study
Description
The related guide on semaglutide fatigue covers the GLP-1-only version of these same symptoms
2024;18(1):e59e69
& Fan, W
In contrast, patients treated with Ozempic often experience more substantial weight loss, averaging approximately 1015% or more of their initial body weight over the same time frame, especially at higher dosages
